ABBV has been in the news 321% more than usual
Jun 19, 2025, 12:31 PM
-0.97%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie Inc reported positive topline results from its Phase 3 TEMPLE study, demonstrating the effectiveness of atogepant in treating adults with four or more migraine days per month. Meanwhile, Democratic lawmakers have criticized pharmaceutical companies, including Johnson & Johnson, for exploiting tax loopholes while making substantial profits.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.